Key result
The Paci2018 in silico model successfully simulated human induced pluripotent stem cell-derived cardiomyocyte action potentials and calcium transients, including delayed afterdepolarizations that previous models could not predict.
Why the study?
Does the updated Paci2018 in silico model better recapitulate Ca2+ handling abnormalities compared to the Paci2013 model in hiPSC-CMs?
Population
Human induced pluripotent stem cell-derived cardiomyocytes in silico model, validated with experimental data…
Comparison
Paci2018 in silico model with updated Ca2+… vs Paci2013 in silico model.
Design
Preclinical
Authors
Loading...
New hiPSC-CM model may refine Ca2+ simulations for cardiotoxicity testing; leaves open experimental validation before broader use.
Does the updated Paci2018 in silico model better recapitulate Ca2+ handling abnormalities compared to the Paci2013 model in hiPSC-CMs?
The updated Paci2018 in silico model of hiPSC-CMs accurately reproduces calcium transients and delayed afterdepolarizations, providing a versatile platform for modeling drug effects and mutations.
Paci et al. (2018) studied In silico modeling of human induced pluripotent stem cell-derived cardiomyocytes (n=15). Paci2018 in silico model vs. Paci2013 model was evaluated on Simulation of action potentials and Ca2+ transients. The Paci2018 in silico model successfully simulated human induced pluripotent stem cell-derived cardiomyocyte action potentials and calcium transients, including delayed afterdepolarizations that previous models could not predict.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: